{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-109258","form_type":"8-K","ticker":"HCA","cik":"0000860730","company_name":"HCA Healthcare, Inc.","filed_at":"2023-04-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.456624+00:00","generated_at":"2026-06-16T21:57:41.113170+00:00","sec_items":["2.02","7.01","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"HCA Healthcare Q1 EPS $4.85 beats prior year; raises 2023 revenue and profit guidance","bullets":["Q1 revenues $15.591B (up 4.3% YoY); net income $1.363B, diluted EPS $4.85 vs $4.14.","Adjusted EBITDA $3.172B vs $2.944B; same facility admissions +4.4%, equivalent admissions +7.5%.","Board declared $0.60/share dividend payable June 30, 2023, record June 16.","Repurchased 3.34M shares for $846M in Q1; $3.74B remaining under authorization.","2023 guidance raised: revenue $62.5-64.5B; EPS $17.25-18.55; Adjusted EBITDA $12.1-12.7B."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-109258","json":"https://secwatch.observer/filing/0001193125-23-109258.json","markdown":"https://secwatch.observer/filing/0001193125-23-109258.md","text":"https://secwatch.observer/filing/0001193125-23-109258.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/860730/000119312523109258/0001193125-23-109258-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/860730/000119312523109258/d431466d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T21:57:41.113170+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"05dc0f19253d688988e4fc8b1ce6b4e49e964683","claim":"HCA Healthcare, Inc. reported first quarter ended March 31, 2023 results: revenue $15.591 billion, net income $1.363 billion, EPS $4.85 per diluted share.","evidence_excerpt":"Revenues in the first quarter of 2023 increased to $15.591 billion, compared to $14.945 billion in the first quarter of 2022. Net income attributable to HCA Healthcare, Inc. totaled $1.363 billion, or $4.85 per diluted share, compared to $1.273 billion, or $4.14 per diluted share, in the first quarter of 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/860730/000119312523109258/0001193125-23-109258-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2023"},{"label":"Revenue","value":"$15.591 billion"},{"label":"Net income","value":"$1.363 billion"},{"label":"EPS","value":"$4.85 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"6f2e93e46aa2fe9a3f8e60379f750598b86b1200","claim":"HCA Healthcare, Inc. reported Full year 2023 results: revenue $62.5 to $64.5 billion, net income $4.750 to $5.160 billion, EPS $17.25 to $18.55 per diluted share. Guidance raised.","evidence_excerpt":"The 2023 guidance ranges for the year have been revised from our fourth quarter release as follows: Previous 2023 Guidance Range as of January 27, 2023 2023 Guidance Range as of April 21, 2023 Revenues $61.5 to 63.5 billion $62.5 to $64.5 billion Net Income Attributable to HCA Healthcare, Inc. $4.525 to $4.895 billion $4.750 to $5.160 billion Adjusted EBITDA $11.8 to $12.4 billion $12.1 to $12.7 billion EPS (diluted) $16.40 to $17.60 per diluted share $17.25 to $18.55 per diluted share","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/860730/000119312523109258/0001193125-23-109258-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Full year 2023"},{"label":"Revenue","value":"$62.5 to $64.5 billion"},{"label":"Net income","value":"$4.750 to $5.160 billion"},{"label":"EPS","value":"$17.25 to $18.55 per diluted share"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}